AbCellera Biologics Inc. (ABCL)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Carl Lars G. Hansen
Employees:
450
2215 YUKON STREET, VANCOUVER, CANADA V5Y 0A1
(604) 559-9005

AbCellera Biologics Inc. has 156 discovery programs that are either completed, in progress, or under contract with 36 partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Data derived from most recent annual or quarterly report
Market Cap 2.975 Billion Shares Outstanding286.1 Million Avg 30-day Volume 1.564 Million
P/E Ratio12.5764 Dividend Yield0.0 EPS
Price to Revenue5.1782 Debt to Equity0.026 EBITDA374.492 Million
Price to Book Value2.4984 Operating Margin55.663399999999996 Enterprise Value2.196 Billion
Current Ratio9.86 EPS Growth0 Quick Ratio9.186
1 Yr BETA 1.251 52-week High/Low 14.97 / 5.42 Profit Margin41.174
Operating Cash Flow Growth-12.5062 Altman Z-Score8.4748 Free Cash Flow to Firm 76.506 Million
Earnings Report2023-02-21

Are you looking for this stock instead?

View SEC Filings from ABCL instead.

View recent insider trading info

Funds Holding ABCL (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABCL

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-06-30:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-21:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-24:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-15:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-03:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    85.1 Thousand total shares from 1 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    50 Thousand total shares from 1 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BOOTH ANDREW CHIEF FINANCIAL OFFICER

    • Officer
    6,089,940 2022-12-20 3

    THERMOPYLAE HOLDINGS LTD.

    • 10% Owner
    55,859,493 2022-12-16 7

    HAYDEN MICHAEL R

    • Director
    497,045 2022-12-01 1

    LO ANDREW

    • Director
    138,556 2022-12-01 1

    HANSEN CARL L. G. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    • 10% Owner
    6,613,691 2022-12-01 5

    LECAULT VERONIQUE CHIEF OPERATING OFFICER

    • Officer
    • Director
    3,392,689 2022-12-01 3

    MONTALBANO JOHN S.

    • Director
    627,045 2022-12-01 3

    STIMART TRYN CHIEF LEGAL OFFICER

    • Officer
    2,658,381 2022-12-01 1

    FALCONER ESTER CHIEF TECHNOLOGY OFFICER

    • Officer
    0 2021-09-23 0

    HAMER JOHN

    • Director
    14,734,623 2021-08-31 0

    DCVC BIO, L.P.

    DCVC BIO GP, LLC

    JNK CAPITAL MANAGEMENT, LLC

    ZNM CAPITAL MANAGEMENT, LLC

    BOGUE ZACHARY

    OCKO MATTHEW

    STEAD KIERSTEN

    • 10% Owner
    24,179,653 2021-06-18 0

    THIEL PETER

    • Director
    14,360,427 2020-12-15 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    BOOTH ANDREW - Officer CHIEF FINANCIAL OFFICER

    2022-12-22 14:31:23 -0500 2022-12-20 M 50,000 $0.19 a 188,500 direct -1.9924 -3.8899 0.0 1 -10.0569 3

    BOOTH ANDREW - Officer CHIEF FINANCIAL OFFICER

    2022-12-22 14:31:23 -0500 2022-12-20 G 50,000 d 138,500 direct -1.9924 -3.8899 0.0 1 -10.0569 3

    BOOTH ANDREW - Officer CHIEF FINANCIAL OFFICER

    2022-12-22 14:31:23 -0500 2022-12-20 M 50,000 d 5,820,481 direct

    THERMOPYLAE HOLDINGS LTD. - > 10% Owner

    2022-12-20 10:18:00 -0500 2022-12-16 P 85,102 $10.10 a 55,859,493 direct 1.8252 -8.0692 1.8252 2 -8.9337 5

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 22:15:03 UTC 3.7577 0.5623 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 21:45:03 UTC 3.7577 0.5623 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 21:15:03 UTC 3.7577 0.5623 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 20:45:03 UTC 3.7469 0.5731 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 20:15:03 UTC 3.7469 0.5731 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 19:45:03 UTC 3.7469 0.5731 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 19:15:04 UTC 3.7469 0.5731 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 18:45:03 UTC 3.7662 0.5538 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 18:15:03 UTC 3.7662 0.5538 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 17:45:03 UTC 3.7662 0.5538 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 17:15:04 UTC 3.7662 0.5538 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 16:45:04 UTC 3.741 0.579 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 16:15:03 UTC 3.741 0.579 1500000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 15:45:03 UTC 3.741 0.579 1400000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 15:15:04 UTC 3.741 0.579 1400000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 14:45:03 UTC 3.741 0.579 1400000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 14:15:03 UTC 3.741 0.579 1400000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 13:45:03 UTC 3.7735 0.5465 1400000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 13:15:04 UTC 3.7735 0.5465 1400000
    ABCELLERA BIOLOGICS INC ABCL 2023-01-31 12:45:03 UTC 3.7735 0.5465 1400000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND ABCL -59115.0 shares, $-584647.35 2022-09-30 N-PORT
    NORTHERN LIGHTS FUND TRUST II- Invenomic Fund ABCL -55702.0 shares, $-658954.66 2022-10-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments